BOK Financial’s LeMaitre Vascular LMAT Stock Holding History

BOK Financial’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$545	–	1399
2024 Q3	$545	Buy	+6	New	+$520	﹤0.01%	1200

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOK Financial's LMAT Position: Q4 2024 in Review

BOK Financial sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 6 shares — an estimated $545 sold.

BOK Financial first reported a position in LMAT in Q3 2024 and held it in 1 quarter. The position peaked at $545 in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

BOK Financial reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
BOK Financial sold 6 LeMaitre Vascular shares in Q4 2024, an estimated $545.
BOK Financial first reported a position in LeMaitre Vascular in Q3 2024 and held it in 1 quarter.
BOK Financial's LeMaitre Vascular position peaked at $545 in Q3 2024.
307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on BOK Financial's 13F filing for Q4 2024, filed 14 Feb 2025.